Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03970863

Focal Therapy for Localized Prostate Cancer

China Medical University Hospital, Taichung, Taiwan

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
China Medical University Hospital · Academic / Other
Sex
Male
Age
40 Years – 90 Years
Healthy volunteers
Not accepted

Summary

To evaluate the cancer control for prostate cancer patients treated with focal therapy.

Detailed description

Traditional treatments for localized prostate cancer are radical prostatectomy and radiotherapy. However, they would carry side effects including urinary incontinence, sexual dysfunction, radiation cystitis and proctitis, leading to great impact on quality of life. Focal therapy of is another emerging treatment strategy for localized prostate cancer. It aims on ablation of the tumor with sparing of healthy prostatic tissue in order to minimize the injury to urinary and sexual function. Besides, owing to the improvement of multiparametric magnetic resonance imaging (mpMRI), the investigators can localize the prostate cancer more precisely and the accessibility of focal therapy is also increased. Literature showed focal ablation of HIFU or cryotherapy for low and intermediate-risk prostate cancer patients yielded in brilliant outcomes. Biopsy in post-treatment one year showed 87% and 94.6% were negative for clinically significant cancer, respectively. Up to 92% of patients did not need salvage treatment in two years. Ninety-one to one hundred precent of patients had no urinary incontinence, and 74% and 81.5% had no erectile dysfunction, respectively. This prospective study aims to evaluate the cancer control and quality of life for prostate cancer patients treated with focal therapy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTProstate Health IndexUse Prostate Health Index for the follow-up after focal therapy.

Timeline

Start date
2020-08-01
Primary completion
2020-11-10
Completion
2021-11-10
First posted
2019-06-03
Last updated
2024-02-09

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03970863. Inclusion in this directory is not an endorsement.